I just came out of a meeting with Daniel Shervin of Northshore hospital in Glenview IL,my new MO....I was concerned in that my PSA that was at 480 a Nov 2021 . Started Firmagon which brought it down to a nadir of 6 and started rising reaching 25 in April 2022. Went on Orgovyx and Xtandi and PSA rapidly went to 4, then 30 days later 2.33 and a month later (now) PSA at 2.03....
Im concerned that the Firmagon failed after just 4 months and now I'm seeing xtandi seemingly stalling and I'm taking steps to plan out my next move.
Shevrin said I shouldn't be worried at all, that my .2.03 PSA down from 2.33 is good news and nothing to worry about saying that wit still having a prostate gland we are not looking for a PSA of zero or below but just a low PSA with no symptoms which is my situation....My layman's thought is with PSA seemingly stalling the Xtandi is failing as the Firmagon just did and that next month PSA will show increase.
I asked about starting docetaxel now and he was very adamant saying there's no need and it would be a mistake at this point.... All I've read on this board has advocated adding docetaxel to the mix... Any input would be welcome ...Thanks!